Literature DB >> 23490217

Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre.

Giuliano Barugola1, Stefano Partelli, Stefano Crippa, Giovanni Butturini, Roberto Salvia, Nora Sartori, Claudio Bassi, Massimo Falconi, Paolo Pederzoli.   

Abstract

OBJECTIVES: Mortality in pancreatic cancer has remained unchanged over the last 20-30 years. The aim of the present study was to analyse survival trends in a selected population of patients submitted to resection for pancreatic cancer at a single institution.
METHODS: Included were 544 patients who underwent pancreatectomy for pancreatic cancer between 1990 and 2009. Patients were categorized into two subgroups according to the decade in which resection was performed (1990-1999 and 2000-2009). Predictors of survival were analysed using univariate and multivariate analyses.
RESULTS: Totals of 114 (21%) and 430 (79%) resections were carried out during the periods 1990-1999 and 2000-2009, respectively (P < 0.0001). Hospital length of stay (16 days versus 10 days; P < 0.001) and postoperative mortality (3% versus 1%; P = 0.160) decreased over time. Median disease-specific survival significantly increased from 16 months in the first period to 29 months in the second period (P < 0.001). Following multivariate analysis, poorly differentiated tumour [hazard ratio (HR) 3.1, P < 0.001], lymph node metastases (HR = 1.9, P < 0.001), macroscopically positive margin (R2) resection (HR = 3.2, P < 0.0001), no adjuvant therapy (HR = 1.6, P < 0.001) and resection performed in the period 1990-1999 (HR = 2.18, P < 0.001) were significant independent predictors of a poor outcome.
CONCLUSIONS: Longterm survival after surgery for pancreatic cancer significantly improved over the period under study. Better patient selection and the routine use of adjuvant therapy may account for this improvement.
© 2013 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2013        PMID: 23490217      PMCID: PMC3843614          DOI: 10.1111/hpb.12073

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  32 in total

Review 1.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

3.  Pancreatic cancer in the general population: Improvements in survival over the last decade.

Authors:  Taylor S Riall; William H Nealon; James S Goodwin; Dong Zhang; Yong-Fang Kuo; Courtney M Townsend; Jean L Freeman
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

4.  Trends in the treatment and outcome of pancreatic cancer in the United States.

Authors:  Nancy N Baxter; Bryan A Whitson; Todd M Tuttle
Journal:  Ann Surg Oncol       Date:  2007-01-17       Impact factor: 5.344

5.  Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy.

Authors:  G Balzano; A Zerbi; G Capretti; S Rocchetti; V Capitanio; V Di Carlo
Journal:  Br J Surg       Date:  2008-03       Impact factor: 6.939

6.  Feasibility of pancreaticoduodenectomy in a nonuniversity tertiary care center: what are the key elements of success?

Authors:  Amit Khithani; Derick Christian; Kevin Lowe; A Joe Saad; Jeffrey D Linder; Paul Tarnasky; D Rohan Jeyarajah
Journal:  Am Surg       Date:  2011-05       Impact factor: 0.688

7.  Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices.

Authors:  Jessica P Simons; Sing Chau Ng; Theodore P McDade; Zheng Zhou; Craig C Earle; Jennifer F Tseng
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

8.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

9.  Pancreatic head cancer: accuracy of CT in determination of resectability.

Authors:  G Karmazanovsky; V Fedorov; V Kubyshkin; A Kotchatkov
Journal:  Abdom Imaging       Date:  2005 Jul-Aug

10.  Survival from cancer of the pancreas in England and Wales up to 2001.

Authors:  E Mitry; B Rachet; M J Quinn; N Cooper; M P Coleman
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

View more
  7 in total

1.  New possibilities and potential benefits for local control in locally recurrent pancreatic cancer.

Authors:  Shane Lloyd; Bryan W Chang
Journal:  J Gastrointest Oncol       Date:  2013-12

Review 2.  Selection criteria in resectable pancreatic cancer: a biological and morphological approach.

Authors:  Domenico Tamburrino; Stefano Partelli; Stefano Crippa; Alberto Manzoni; Angela Maurizi; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

3.  Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence?

Authors:  Domenico Tamburrino; Giovanni Guarneri; Gabriele Capurso; Massimo Falconi; Michele Pagnanelli; Stefano Crippa; Stefano Partelli; Giulio Belfiori
Journal:  Ann Surg Oncol       Date:  2020-09-12       Impact factor: 5.344

4.  The association of adjuvant therapy with survival at the population level following pancreatic adenocarcinoma resection.

Authors:  Daniel J Kagedan; Ravish S Raju; Matthew E Dixon; Elizabeth Shin; Qing Li; Ning Liu; Maryam Elmi; Abraham El-Sedfy; Lawrence Paszat; Alexander Kiss; Craig C Earle; Nicole Mittmann; Natalie G Coburn
Journal:  HPB (Oxford)       Date:  2016-02-09       Impact factor: 3.647

5.  Ratio of CA19-9 level to total bilirubin as a novel prognostic indicator in patients with pancreatic head carcinoma following curative resection.

Authors:  Wen-Li Xu; Jing Wang; Shao-Cheng Lyu; Lin Zhou; Qiang He; Ren Lang
Journal:  Gland Surg       Date:  2021-03

6.  Preoperative Clinical and Computed Tomography (CT)-Based Nomogram to Predict Oncologic Outcomes in Patients with Pancreatic Head Cancer Resected with Curative Intent: A Retrospective Study.

Authors:  Shin Hye Hwang; Ha Yan Kim; Eun Ju Lee; Ho Kyoung Hwang; Mi-Suk Park; Myeong-Jin Kim; Woo Jung Lee; Yong Eun Chung; Chang Moo Kang
Journal:  J Clin Med       Date:  2019-10-21       Impact factor: 4.241

7.  CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Prognostic Biomarker in Patients with Pancreatic Head Carcinoma.

Authors:  Shao-Cheng Lyu; Jing Wang; Mengxiu Huang; Han-Xuan Wang; Lin Zhou; Qiang He; Ren Lang
Journal:  Cancer Manag Res       Date:  2021-06-21       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.